We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

57 hedge funds and large institutions have $20.2M invested in Perspective Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more capital invested

Capital invested by funds: $4.12M → $20.2M (+$16.1M)

300% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 4

175% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 8

33% more funds holding

Funds holding: 43 → 57 (+14)

0.33% more ownership

Funds ownership: 0.99% → 1.31% (+0.33%)

Holders
57
Holders Change
+14
Holders Change %
+32.56%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
16
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.16M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.89M
3
BlackRock
BlackRock
New York
+$2.85M
4
PCM
Perkins Capital Management
Minnesota
+$1.36M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$998K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$87K
2
UBS Group
UBS Group
Switzerland
-$74.2K
3
VF
Virtu Financial
New York
-$72.3K
4
Squarepoint
Squarepoint
New York
-$54K
5
TRCT
Tower Research Capital (TRC)
New York
-$53.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
IFS
26
Ifrah Financial Services
Arkansas
$33K – – –
BBNA
27
Bremer Bank National Association
Minnesota
$32K +$44.4K +2,941 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$28K +$38.3K +2,534 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$27K +$4.23K +280 +13%
RJFSA
30
Raymond James Financial Services Advisors
Florida
$25K +$2.72K +180 +9%
Victory Capital Management
31
Victory Capital Management
Texas
$25K +$12.6K +833 +57%
TWM
32
TMD Wealth Management
Arizona
$22K – – –
HighTower Advisors
33
HighTower Advisors
Illinois
$21K +$28.8K +1,907 New
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$15K -$9.91K -656 -32%
AAM
35
Auxier Asset Management
Oregon
$15K – – –
EGM
36
Engineers Gate Manager
New York
$13K +$18K +1,190 New
State Street
37
State Street
Massachusetts
$12K – – –
CAI
38
Capital Advisors Inc
Oklahoma
$11K – – –
SWP
39
Stratos Wealth Partners
Ohio
$11K +$15.1K +1,000 New
Walleye Trading
40
Walleye Trading
New York
$11K +$15.7K +1,039 New
Wells Fargo
41
Wells Fargo
California
$7K +$6.62K +438 +241%
TRCT
42
Tower Research Capital (TRC)
New York
$5K -$53.8K -3,560 -89%
JFA
43
JNBA Financial Advisors
Minnesota
$5K – – –
TCWM
44
Total Clarity Wealth Management
Illinois
$5K +$6.25K +414 New
Morgan Stanley
45
Morgan Stanley
New York
$2K – – –
Osaic Holdings
46
Osaic Holdings
Arizona
$2K – – –
Barclays
47
Barclays
United Kingdom
$2K +$2.63K +174 New
HI
48
Harbour Investments
Wisconsin
$2K +$2.87K +190 New
UBS Group
49
UBS Group
Switzerland
$1K -$74.2K -4,915 -99%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$1K +$1.81K +120 New
1
2
3

CATX Hedge Fund Activity: Q1 2021 in Review

57 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2021, worth a combined $20.2M — up 389% from $4.12M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CATX positions and 8 closed out — a net gain of 14 holders — while 16 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.16M. The largest seller was Anson Funds Management, exiting entirely with an estimated $87K sold.

  • 57 institutional investors held Perspective Therapeutics (CATX) as of Q1 2021, up from 43 in Q4 2020.
  • Funds reported $20.2M of Perspective Therapeutics stock for Q1 2021, up 389% quarter-over-quarter.
  • 22 funds opened new Perspective Therapeutics positions in Q1 2021 and 8 closed out, a net change of +14 holders.
  • The largest Perspective Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $5.16M added.
  • The largest Perspective Therapeutics seller in Q1 2021 was Anson Funds Management, an estimated $87K sold.

Based on aggregated 13F filings for Q1 2021.